PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia

scientific article published on 14 March 2006

PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LEUKRES.2006.02.004
P698PubMed publication ID16533526

P2093author name stringTomoko Yamamoto
Hitoshi Kiyoi
Tomoki Naoe
Hiroshi Yagasaki
Juan Liang
Kazuko Kudo
Yoshiro Kamachi
Yinyan Xu
Mariko Isomura
Seiji Kojma
P433issue9
P921main subjectleukemiaQ29496
P304page(s)1085-1089
P577publication date2006-03-14
P1433published inLeukemia ResearchQ15716445
P1476titlePTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia
P478volume30

Reverse relations

cites work (P2860)
Q79777437A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome
Q36905741A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma
Q41535044Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.
Q34143049Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia
Q89475164CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
Q46220127Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia
Q84713544Cytogenetics and molecular genetics of acute lymphoblastic leukemia
Q33778374FLT3 Internal Tandem Duplication and D835 Mutations in Patients with Acute Lymphoblastic Leukemia and its Clinical Significance
Q46944335FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns
Q33704528FLT3mutation incidence and timing of origin in a population case series of pediatric leukemia
Q41407670Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival
Q54406965Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil.
Q34503441Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
Q37142140Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
Q35220417Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
Q36290242Molecular genetics of B-precursor acute lymphoblastic leukemia
Q51753853Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution.
Q47884832Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia
Q46971359Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.
Q33722741Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
Q35101627Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
Q103028965RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
Q38227885Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting
Q36989335Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2.
Q38460308The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.
Q37732956The tyrosine phosphatase Shp2 in development and cancer
Q33401984Wiskott-Aldrich syndrome with unusual clinical features similar to juvenile myelomonocytic leukemia

Search more.